Literature DB >> 22153076

Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.

Noam Levaot1, Oleksandr Voytyuk, Ioannis Dimitriou, Fabrice Sircoulomb, Arun Chandrakumar, Marcel Deckert, Paul M Krzyzanowski, Andrew Scotter, Shengqing Gu, Salima Janmohamed, Feng Cong, Paul D Simoncic, Yasuyoshi Ueki, Jose La Rose, Robert Rottapel.   

Abstract

Cherubism is an autosomal-dominant syndrome characterized by inflammatory destructive bony lesions resulting in symmetrical deformities of the facial bones. Cherubism is caused by mutations in Sh3bp2, the gene that encodes the adaptor protein 3BP2. Most identified mutations in 3BP2 lie within the peptide sequence RSPPDG. A mouse model of cherubism develops hyperactive bone-remodeling osteoclasts and systemic inflammation characterized by expansion of the myelomonocytic lineage. The mechanism by which cherubism mutations alter 3BP2 function has remained obscure. Here we show that Tankyrase, a member of the poly(ADP-ribose)polymerase (PARP) family, regulates 3BP2 stability through ADP-ribosylation and subsequent ubiquitylation by the E3-ubiquitin ligase RNF146 in osteoclasts. Cherubism mutations uncouple 3BP2 from Tankyrase-mediated protein destruction, which results in its stabilization and subsequent hyperactivation of the SRC, SYK, and VAV signaling pathways.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22153076      PMCID: PMC3475183          DOI: 10.1016/j.cell.2011.10.045

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  32 in total

1.  Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.

Authors:  Y Ueki; V Tiziani; C Santanna; N Fukai; C Maulik; J Garfinkle; C Ninomiya; C doAmaral; H Peters; M Habal; L Rhee-Morris; J B Doss; S Kreiborg; B R Olsen; E Reichenberger
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

2.  TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres.

Authors:  William Chang; Jasmin N Dynek; Susan Smith
Journal:  Genes Dev       Date:  2003-06-01       Impact factor: 11.361

3.  3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions.

Authors:  Noam Levaot; Paul D Simoncic; Ioannis D Dimitriou; Andrew Scotter; Jose La Rose; Adeline H M Ng; Thomas L Willett; Chiachien J Wang; Salima Janmohamed; Marc Grynpas; Ernst Reichenberger; Robert Rottapel
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

Review 4.  Role of Src expression and activation in human cancer.

Authors:  R B Irby; T J Yeatman
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

5.  Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins.

Authors:  J M Pleschke; H E Kleczkowska; M Strohm; F R Althaus
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

6.  Regulation of FcepsilonRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells.

Authors:  Kiyonao Sada; S M Shahjahan Miah; Koichiro Maeno; Shinkou Kyo; Xiujuan Qu; Hirohei Yamamura
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

7.  Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho.

Authors:  P Cicchetti; B J Mayer; G Thiel; D Baltimore
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

8.  A proteomic approach to the identification of heterogeneous nuclear ribonucleoproteins as a new family of poly(ADP-ribose)-binding proteins.

Authors:  Jean-Philippe Gagné; Joanna M Hunter; Benoît Labrecque; Benoît Chabot; Guy G Poirier
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

9.  Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers.

Authors:  Jon R Wiener; T Christopher Windham; Veronica C Estrella; Nila U Parikh; Peter F Thall; Michael T Deavers; Robert C Bast; Gordon B Mills; Gary E Gallick
Journal:  Gynecol Oncol       Date:  2003-01       Impact factor: 5.482

Review 10.  Tyrosine kinase signalling in breast cancer.

Authors:  N E Hynes
Journal:  Breast Cancer Res       Date:  2000-04-17       Impact factor: 6.466

View more
  83 in total

1.  GDP-mannose-4,6-dehydratase is a cytosolic partner of tankyrase 1 that inhibits its poly(ADP-ribose) polymerase activity.

Authors:  Kamlesh K Bisht; Charles Dudognon; William G Chang; Ethan S Sokol; Alejandro Ramirez; Susan Smith
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

2.  Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein.

Authors:  Chien-Hung Liu; Ligang Zhou; Guifang Chen; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-26       Impact factor: 11.205

3.  The molecular basis of cherubism.

Authors: 
Journal:  Bonekey Rep       Date:  2012-02-01

Review 4.  Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.

Authors:  Bertrand Boisson; Pierre Quartier; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2015-01-31       Impact factor: 7.486

5.  Investigating global gene expression changes in a murine model of cherubism.

Authors:  Tulika Sharma; Justin Cotney; Vijender Singh; Archana Sanjay; Ernst J Reichenberger; Yasuyoshi Ueki; Peter Maye
Journal:  Bone       Date:  2020-03-10       Impact factor: 4.398

Review 6.  Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases.

Authors:  Vinayak Vittal; Mikaela D Stewart; Peter S Brzovic; Rachel E Klevit
Journal:  J Biol Chem       Date:  2015-07-17       Impact factor: 5.157

7.  Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2.

Authors:  Yoshinori Matsumoto; Jose La Rose; Oliver A Kent; Melany J Wagner; Masahiro Narimatsu; Aaron D Levy; Mitchell H Omar; Jiefei Tong; Jonathan R Krieger; Emily Riggs; Yaryna Storozhuk; Julia Pasquale; Manuela Ventura; Behzad Yeganeh; Martin Post; Michael F Moran; Marc D Grynpas; Jeffrey L Wrana; Giulio Superti-Furga; Anthony J Koleske; Ann Marie Pendergast; Robert Rottapel
Journal:  J Clin Invest       Date:  2016-10-31       Impact factor: 14.808

8.  RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146.

Authors:  Yoshinori Matsumoto; Jose Larose; Oliver A Kent; Melissa Lim; Adele Changoor; Lucia Zhang; Yaryna Storozhuk; Xiaohong Mao; Marc D Grynpas; Feng Cong; Robert Rottapel
Journal:  J Clin Invest       Date:  2017-03-13       Impact factor: 14.808

Review 9.  Targeting Wnt pathways in disease.

Authors:  Zachary F Zimmerman; Randall T Moon; Andy J Chien
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

10.  Cloning and characterization of the human SH3BP2 promoter.

Authors:  Chun Fan; Robert J Gaivin; Thomas A Marth; Belinda Willard; Michael A Levine; Steven A Lietman
Journal:  Biochem Biophys Res Commun       Date:  2012-07-17       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.